Superior Formulations

The Patchless Patch Delivery System

MNP nanotechnology is broad based and amenable to formulating more than 60% of currently approved APIs.

We have achieved therapeutic blood levels with over 20 molecules from multiple therapeutic categories.

Key salient features of the MNP Nanoformulations:

  • Rapid uptake; quick penetration
  • Sustained release; depot effect
    • Once a day application feasible for most drugs
  • Flexibility in altering characteristics of formulation
  • High drug loading capability (up to 20% w/w achieved so far)
  • Unlimited skin surface area (unlike patches)
  • Same formulation can be used to deliver different amounts of drug – by varying application volumes

SGN Nanopharma offers a much broader physicochemical property range of APIs that can be delivered via MNP as compared to other technologies.

  • First to deliver naltrexone transdermally
  • Alendronate (Fosamax®), highly charged, difficult to formulate.
  • Raloxifene (Evista®)
  • Difficult to solubilize API’s

Find out more about our key areas of application. Go to Research.

Get News Updates